DE69707104D1 - Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe - Google Patents

Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe

Info

Publication number
DE69707104D1
DE69707104D1 DE69707104T DE69707104T DE69707104D1 DE 69707104 D1 DE69707104 D1 DE 69707104D1 DE 69707104 T DE69707104 T DE 69707104T DE 69707104 T DE69707104 T DE 69707104T DE 69707104 D1 DE69707104 D1 DE 69707104D1
Authority
DE
Germany
Prior art keywords
pct
spiro
active substances
therapeutic active
ketal derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69707104T
Other languages
English (en)
Other versions
DE69707104T2 (de
Inventor
Matthew Elliott
Fintan Kelleher
John Swain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of DE69707104D1 publication Critical patent/DE69707104D1/de
Application granted granted Critical
Publication of DE69707104T2 publication Critical patent/DE69707104T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69707104T 1996-02-15 1997-02-12 Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe Expired - Fee Related DE69707104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603137.2A GB9603137D0 (en) 1996-02-15 1996-02-15 Therapeutic agents
PCT/GB1997/000383 WO1997030055A1 (en) 1996-02-15 1997-02-12 Spiro-ketal derivatives and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
DE69707104D1 true DE69707104D1 (de) 2001-11-08
DE69707104T2 DE69707104T2 (de) 2002-06-20

Family

ID=10788765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69707104T Expired - Fee Related DE69707104T2 (de) 1996-02-15 1997-02-12 Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe

Country Status (9)

Country Link
US (1) US6127365A (de)
EP (1) EP0880528B1 (de)
JP (1) JP2000505442A (de)
AT (1) ATE206428T1 (de)
AU (1) AU716691B2 (de)
DE (1) DE69707104T2 (de)
ES (1) ES2163730T3 (de)
GB (1) GB9603137D0 (de)
WO (1) WO1997030055A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929094A (en) * 1996-10-25 1999-07-27 Merck & Co., Inc. Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
GB9625843D0 (en) * 1996-12-12 1997-01-29 Merck & Co Inc Phenyl spiroethercycloalkyl tachykinn receptor antagonists
US6335364B1 (en) * 1998-06-29 2002-01-01 Parker Hughes Institute Synthetic spiroketal pyranes as potent anti-cancer agents
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
BR0314713A (pt) * 2002-09-24 2005-07-26 Combinatorx Inc Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
DE102007010077B4 (de) * 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
JP6891386B2 (ja) * 2015-10-23 2021-06-18 エステベ ファーマシューティカルズ, ソシエダッド アノニマEsteve Pharmaceuticals, S.A. 疼痛に対して活性を有するオキサ−アザスピロ化合物
US11425169B2 (en) 2016-03-11 2022-08-23 Netskope, Inc. Small-footprint endpoint data loss prevention (DLP)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106142A (en) * 1992-06-29 1997-03-18 Merck & Co Inc Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
CA2154569A1 (en) * 1993-01-28 1994-08-04 Jeffrey J. Hale Spiro-substituted azacycles as tachykinin receptor antagonists
CA2157117C (en) * 1993-03-04 1999-01-05 Manoj C. Desai Spirocyclic piperidine derivatives
EP0702681A1 (de) * 1993-06-07 1996-03-27 Merck & Co. Inc. Spiro-substituierte azaringe als neurokinin antagonisten
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9426103D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
ATE206428T1 (de) 2001-10-15
EP0880528B1 (de) 2001-10-04
GB9603137D0 (en) 1996-04-17
US6127365A (en) 2000-10-03
EP0880528A1 (de) 1998-12-02
ES2163730T3 (es) 2002-02-01
AU1799297A (en) 1997-09-02
DE69707104T2 (de) 2002-06-20
JP2000505442A (ja) 2000-05-09
WO1997030055A1 (en) 1997-08-21
AU716691B2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
DE69528823T2 (de) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
ES2120170T3 (es) Antagonistas azaciclicos gem-disustituidos de taquiquininas.
ATE247096T1 (de) Tetrahydropyranderivate und deren verwendung als therapeutische mittel
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
ATE340781T1 (de) Cyclohexylderivate und ihre anwendung als therapeutische mittel
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
DE60112055D1 (de) Inhibitoren von gamma-secretase
DE60134874D1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
DE69521208D1 (de) Morpholinderivate und ihre verwendung als therapeutische mittel
ATE320432T1 (de) Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten
TR199900856T2 (xx) Bron�la ilgili terapi maddeleri olarak benzonaftiridinler
DE69707104D1 (de) Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe
NO20022920D0 (no) Nye forbindelser
BG105710A (en) 5ht1 antagonists for antidepressant therapy
ATE187956T1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
DE69512940D1 (de) N-hydroxy-harnstoff-derivate als entzündunghemmende mittel
DE69311123T2 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee